ENDRA LIFE SCIENCES INC. Fair Value Adjustment of Warrants
ENDRA LIFE SCIENCES INC. (NDRA) reported Fair Value Adjustment of Warrants of $66.70 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. fair value adjustment of warrants for the quarter ending 2026-06-30 was $66.70K.
- ENDRA LIFE SCIENCES INC. fair value adjustment of warrants for the quarter ending 2026-03-31 was $8.86K.
- ENDRA LIFE SCIENCES INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$116.14K.
- ENDRA LIFE SCIENCES INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was $267.27K.
- ENDRA LIFE SCIENCES INC. fair value adjustment of warrants for fiscal 2025 was -$319.54K.
- ENDRA LIFE SCIENCES INC. fair value adjustment of warrants for fiscal 2024 was -$3.45M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $66.70K 10-Q · filed 2026-08-14 | $75.56K 10-Q · filed 2026-08-14 | -$40.58K derived: sum of 3 quarters · filed 2026-08-14 | $226.70K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $8.86K 10-Q · filed 2026-05-15 | -$107.28K derived: sum of 2 quarters · filed 2026-05-15 | $159.99K derived: sum of 3 quarters · filed 2026-05-15 | $97.88K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$116.14K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $151.14K derived: sum of 2 quarters · filed 2026-03-31 | $89.03K derived: sum of 3 quarters · filed 2026-08-14 | -$319.54K 10-K · filed 2026-03-31 |
| 2025-09-30 | $267.27K 10-Q · filed 2025-11-14 | $205.16K derived: sum of 2 quarters · filed 2026-08-14 | -$203.40K 10-Q · filed 2025-11-14 | -$309.31K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$62.11K 10-Q · filed 2026-08-14 | -$470.67K 10-Q · filed 2026-08-14 | -$576.58K derived: sum of 3 quarters · filed 2026-08-14 | -$3.92M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$408.56K 10-Q · filed 2026-05-15 | -$514.47K derived: sum of 2 quarters · filed 2026-05-15 | -$3.86M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$105.91K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$3.45M derived: sum of 2 quarters · filed 2026-03-31 | -$3.45M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$3.34M 10-Q · filed 2025-11-14 | -$3.34M 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |